Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2003
05/22/2003US20030095926 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
05/22/2003CA2784450A1 Polypeptides of pseudomonas aeruginosa
05/22/2003CA2649826A1 Synthesis and purification of valacyclovir
05/22/2003CA2466998A1 Biocompatible polymer blends and uses thereof
05/22/2003CA2466975A1 Macrolides
05/22/2003CA2466843A1 Salmonella vaccine
05/22/2003CA2464861A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003CA2464347A1 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5)
05/22/2003CA2461577A1 Novel c-3 s/o- and s/n formaldehe acetal derivatives of cephalosporins and their use as antibiotics
05/22/2003CA2460959A1 Enzymes
05/22/2003CA2460027A1 Medical devices having antimicrobial coatings thereon
05/21/2003WO2004041156A2 Method for determining sensitivity to a bacteriophage
05/21/2003EP1312679A1 Recombinant MVA virus, and the use thereof
05/21/2003EP1312678A1 Recombinant MVA virus, and the use thereof
05/21/2003EP1312667A1 Probiotics products containing lactic acid bacterium
05/21/2003EP1312609A1 Boronic ester and acid compounds, synthesis and uses
05/21/2003EP1312607A1 Dithiocarbamate derivatives and their use as antibacterial agents
05/21/2003EP1312371A1 Animal papilla disinfectants and method of improving microbial environment
05/21/2003EP1312370A1 Composition comprising dried whole egg for treating hepatitis
05/21/2003EP1312367A1 Heterocyclo-alkylsulfonyl pyrazolesa and their use as COX-2 inhibitors
05/21/2003EP1312366A1 Aqueous pharmaceutical compositions
05/21/2003EP1312356A1 Aqueous suspension preparations
05/21/2003EP1312262A1 Powders having contact biocidal properties
05/21/2003EP1311686A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
05/21/2003EP1311684A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
05/21/2003EP1311677A2 Regulation of human p2y1-like g protein-coupled receptor
05/21/2003EP1311672A1 New sequences
05/21/2003EP1311539A2 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
05/21/2003EP1311538A2 Inhibitors of hiv replication and method of treatment of hiv infections
05/21/2003EP1311534A1 Thioether-sulphamate steroids as steroid sulphatase inhibitors and anti-cancer compounds
05/21/2003EP1311533A1 17-aryl-linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
05/21/2003EP1311532A1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
05/21/2003EP1311531A1 Steroid derived antibiotics
05/21/2003EP1311525A2 Composition and method for inhibiting platelet aggregation
05/21/2003EP1311507A1 Fused pyrazole derivatives being protein kinase inhibitors
05/21/2003EP1311498A1 Diamino phenothiazine derivatives and composition comprising same
05/21/2003EP1311497A1 Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (iv)
05/21/2003EP1311491A1 Use of triazinetrione sulfones for combating coccidiosis
05/21/2003EP1311489A1 Biphenyl derivatives and the use thereof as integrin inhibitors
05/21/2003EP1311484A1 Biphenyl derivatives and the use thereof as integrin inhibitors
05/21/2003EP1311475A1 Novel aminocyclohexane derivatives
05/21/2003EP1311473A2 Novel compounds inhibiting factor xa activity
05/21/2003EP1311296A2 Solution of an oxazolidinone antibiotic drug
05/21/2003EP1311291A2 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists
05/21/2003EP1311289A2 Vaccines containing ribavirin and methods of use thereof
05/21/2003EP1311288A1 Immunostimulatory nucleic acids for inducing a th2 immune response
05/21/2003EP1311285A2 Liquid pharmaceutical composition containing an erythropoietin derivative
05/21/2003EP1311281A1 Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
05/21/2003EP1311279A1 Treatment of hepatitis c with thymosin, interferon and ribavirin
05/21/2003EP1311270A1 Non-sedating barbiturate compounds as neuroprotective agents
05/21/2003EP1311269A2 Method of using diketopiperazines and composition containing them
05/21/2003EP1311268A1 Imidazopyridine and imidazopyrimidine antiviral agents
05/21/2003EP1311267A1 A retroviral immunotherapy
05/21/2003EP1311266A2 Combination hiv therapy including camptothecin
05/21/2003EP1311263A2 Fused pyrrolocarbazoles against inflammation
05/21/2003EP1311261A1 Medicaments for chemotherapeutic treatment of disease
05/21/2003EP1311259A2 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent
05/21/2003EP1311255A1 Compounds having mif antagonist activity
05/21/2003EP1311254A2 METHODS FOR TREATING SUBJECTS INFECTED WITH A HERPES VIRUS OR i NEISSERIA GONORRHEAE /i
05/21/2003EP1311237A2 Use of cyclic 2,4-diphosphoglycerates (cdgp) and/or derivatives thereof in cosmetic and dermatological formulations
05/21/2003EP1311236A1 Use of beta-mannosylglycerate and derivatives in cosmetic and dermatological formulations
05/21/2003EP1283711A4 Peptide deformylase inhibitors
05/21/2003EP1244444A4 Process for formulation of carbapenem antibiotic compositions
05/21/2003EP1242439B1 Method for preparing and isolating 9-deoxo-9(z)-hydroxyiminoerythromycin a
05/21/2003EP1204675B1 Streptogramin derivatives, production thereof and compositions containing the same
05/21/2003EP1189932B1 Novel echinocandin derivatives, method for preparing the same and use as antifungal agents
05/21/2003EP1186607B1 Optically active pyrrolopyridazine compounds
05/21/2003EP1173439B1 Haloalkoxy imidazonaphthyridines
05/21/2003EP1131334A4 Use of core 2 glcnac transferase inhibitors in treating inflammation
05/21/2003EP1115701B1 Arylsulfonanilide ureas
05/21/2003EP1015593B1 Hepatitis b virus polypeptides
05/21/2003EP1009732B1 1-amino-alkylcyclohexane nmda receptor antagonists
05/21/2003EP0988042A4 A combination therapy for hiv infections
05/21/2003EP0918528B1 Use of hyperimmunized milk and/or egg for treating gastrointestinal damage
05/21/2003EP0876613B1 Treatment and diagnosis of infections due to helicobacter pylori
05/21/2003EP0866801B1 Cyclopeptolides
05/21/2003EP0837699B1 Immunovectors for the intracellular and intranuclear transport
05/21/2003EP0817640B1 Use of epithelial adhesive lactobacilli
05/21/2003EP0792148B1 Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity
05/21/2003EP0706394B1 Use of a compostion comprising histamine phosphate for the manufacture of a medicament for the topical treatment of epithelial inflammation or lesions
05/21/2003EP0633931B1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
05/21/2003CN1419565A Chimeric Prostate-homing peptides with pro-apoptotic activity
05/21/2003CN1419564A Proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA
05/21/2003CN1419563A Peptide derivative
05/21/2003CN1419560A Anti-infective actatm
05/21/2003CN1419559A Tricyclic protein kinase inhibitors
05/21/2003CN1419553A Prodigiosin-derivatives as neoplastic and anti-viral agents
05/21/2003CN1419552A 2-amino-3-(alkyl)-pyrimidone derivatives as GSKS beta. inhibitors
05/21/2003CN1419545A 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
05/21/2003CN1419542A Heterocyclic acylsulfimides, a method for their production, agents containing the same and their use as pesticides 403
05/21/2003CN1419541A Pharmaceutically active pyrrolidine derivatives as BAX inhibitors
05/21/2003CN1419539A Amidino compound and salts thereof useful as nitric oxide synahase inhibitors
05/21/2003CN1419456A Vaccine for the prophylactic or therapeutic immunization against HIV
05/21/2003CN1419454A Use of lactic acid bacterium for the treatment of peritonitis
05/21/2003CN1419450A Nitrite salts of antimicrobial agents
05/21/2003CN1419447A Diphenyl ketoaldehyde derivatives with anti-HIV activity
05/21/2003CN1419445A Agent and binding agent for pharmaceutical formulations with improved storage stability
05/21/2003CN1418966A Resoldution method for racemic compound of nucleoside enantiomorph
05/21/2003CN1418887A Aminoglycoside compound having antiviral activity
05/21/2003CN1418879A Process for preparing 8-methoxy-quinolone
1 ... 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 ... 1798